跳至主要内容
临床试验/NCT00190944
NCT00190944已完成2 期

Effects of Teriparatide on Distal Radius Fracture Healing

Eli Lilly and Company8 个研究点 分布在 5 个国家目标入组 105 人开始时间: 2004年12月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
105
试验地点
8
主要终点
Time to radiographic healing

研究概览

简要总结

Effects of Teriparatide on Distal Radius Fracture Healing

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
45 Years 至 85 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Ambulatory, postmenopausal, women 45 to 85 years of age. Postmenopausal is defined as at least 2 years without regular menses
  • Sustained a unilateral, dorsally angulated fracture of the distal radius within 10 days
  • Received conservative treatment of her distal radius fracture, including closed reduction and immobilization device (such as cast, splint, or brace)
  • Free of severe or chronically disabling conditions other than a distal radius fracture as determined by the investigator
  • Without language barrier, cooperative, expected to return for all follow-up procedures, and has given informed consent before entering the study and after being informed of the risks, medications and procedures to be used in the study.
  • In the opinion of the investigator, the patient is willing to be trained and use the pen-injector daily, is able to satisfactorily use a pen-type injection delivery system, or is willing to receive daily subcutaneous injections from a care partner who has been trained to use the pen injector

排除标准

  • Increased baseline risk of osteosarcoma
  • History of a malignant neoplasm in the 5 years prior to visit 2, with the exception of superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitely treated
  • Have currently known, suspected, or history of other diseases that affect bone metabolism other than postmenopausal osteoporosis or cause secondary osteoporosis that has been clinically active in the 1 year prior to visit 2
  • Have elevated serum calcium values
  • Active liver disease or clinical jaundice
  • History of symptomatic nephro-or urolithiasis in the 2 years prior to visit 2
  • Previous fractures or bone surgery in the currently fractured distal forearm
  • Joint disease such as rheumatoid arthritis or disabling osteoarthritis that clearly affect the function of the wrist and/or hand of the injured arm
  • Requirement for chronic treatment with nonsteroidal anti-inflammatory drugs defined as more than 3 consecutive months of any NSAID treatment
  • Treatment with:
  • Oral bisphosphonates for more than 18 months during the prior 3 years, or have received any oral or intravenous biphosphonate therapy within the last 2 months prior to screening.
  • Oral strontium ranelate for any duration
  • Systemic corticosteroids for more than 30 days (total) in the 6 months prior to visit 2, or any systemic corticosteroid dose in the 1 month prior to visit
  • Ophthalmic, oric, topical, or nasally inhaled corticosteroid therapy may be used without these restrictions.
  • Fluoride at therapeutic doses (greater than or equal to 20mg/day) for more than 3 months during the last 2 years or for more than a total of 2 years, or any dosages within the 6 months prior to visit 2.

结局指标

主要结局

Time to radiographic healing

次要结局

  • There are no secondary outcomes for this trial

研究者

申办方类型
Industry

研究点 (8)

Loading locations...

相似试验